Showing results (21-30 of 27) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 3, 2010
Detection of early-stage pancreatic adenocarcinomaDavid V Gold, Michael Goggins, David E Modrak, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2004
Improved targeting of pancreatic cancer: experimental studies of a new bispecific antibody, pretargeting enhancement system for immunoscintigraphyThomas M Cardillo, Habibe Karacay, David M Goldenberg, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 2, 2009
Pretargeted radioimmunotherapy of pancreatic cancer xenografts: TF10-90Y-IMP-288 alone and combined with gemcitabineHabibe Karacay, Robert M Sharkey, David V Gold, et al.Cancer Research|June 19, 2008
A novel bispecific, trivalent antibody construct for targeting pancreatic carcinomaDavid V Gold, David M Goldenberg, Habibe Karacay, et al.International Journal of Cancer|July 29, 2011
Horizontal transmission and retention of malignancy, as well as functional human genes, after spontaneous fusion of human glioblastoma and hamster host cells in vivoDavid M Goldenberg, David Zagzag, Kerstin M Heselmeyer-Haddad, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 30, 2011
Treatment of advanced pancreatic carcinoma with 90Y-Clivatuzumab Tetraxetan: a phase I single-dose escalation trialSeza A Gulec, Steven J Cohen, Kenneth L Pennington, et al.Cancer|May 10, 2012
Fractionated radioimmunotherapy with (90) Y-clivatuzumab tetraxetan and low-dose gemcitabine is active in advanced pancreatic cancer: A phase 1 trialAllyson J Ocean, Kenneth L Pennington, Michael J Guarino, et al.Pageof 3